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Exercise in ARVD/C*
Daniel P. Judge, MD, Stephen P. Chelko, PHDExercise is loathsome. And it cannot be
any beneﬁt when you are tired,
and I was always tired.
—Mark Twain (1)T he evidence implicating exercise as a patho-genic factor in arrhythmogenic right ventric-ular dysplasia/cardiomyopathy (ARVD/C)
continues to grow. Early reports of this condition
recognized its occurrence with athletic activity, and
later studies strengthened this association (2,3).
Retrospective quantiﬁcation of exercise for 87 people
with desmosome mutations demonstrated that those
with the highest levels of exercise developed earlier
and more severe manifestations of this inherited car-
diomyopathy (3). In a complementary analysis of 82
patients with ARVD/C, those without desmosomal
mutations or family history of ARVD/C had per-
formed more intense exercise (4). These ﬁndings sup-
port an emerging paradigm in which both genetic
predisposition and environmental factors interact
around a threshold for phenotypic expression of
ARVD/C (5).SEE PAGE 1438Many questions remain regarding the pathogenesis
of ARVD/C, and in this issue of the Journal, Cruz et al.
(6) highlight an alternative approach to its investi-
gation. Using an adeno-associated virus (AAV)–
mediated gene transfer protocol, they overexpressed
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PKP2 p.Arg735Ter mutation, led to cardiac production
of truncated plakophilin-2 for 10 months. Unfortu-
nately, thiswas insufﬁcient for recapitulating ARVD/C.
However, on the basis of prior human, murine, and
cellular studies implicating exercise as harmful in the
context of desmosome mutation (3,7,8), Cruz et al.
(6) subjected these AAV-treated mice to forced
swim exercise. Indeed, exercised PKP2 mutant mice
demonstrated reduced global right ventricular (RV)
ejection fraction compared with exercised mice with
wild-type PKP2 transgene or sedentary mutant mice.
This work is notable for some important ﬁndings.
The authors demonstrate that AAV achieves robust
cardiac expression, with recapitulation of RV dys-
function induced by the addition of mutant human
PKP2. We can explain more than 50% of this
disease on the basis of a desmosome mutation, yet
rare or novel variation in these genes commonly
occurs among asymptomatic control subjects (9,10).
The use of this technology would allow uncertain
desmosome variants to be assessed similarly, which is
certainly easier than generating mice with knock-in
mutations. Somewhat surprisingly, the investigators
were able to induce cardiac dysfunction despite a
normal content of murine plakophilin-2 by over-
expressing the truncated human protein. The majority
of PKP2 mutations led to premature transcript
termination, which suggests it is caused by insufﬁ-
cient protein. Furthermore, Pkp2 haploinsufﬁciency
led to sodium current deﬁcits in murine hearts, and
PKP2 knockdown in HL-1 myocytes produced features
of ARVD/C (11,12). However, the initial report of
PKP2 mutations causing ARVD/C demonstrated that
some truncating mutations have normal mutant
PKP2 messenger ribonucleic acid content, without
degradation by nonsense-mediated messenger ribo-
nucleic acid decay (13). The ﬁndings by Cruz et al.
(6) add further support for a dominant-negative
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tion to prior evidence regarding haploinsufﬁciency.
This work also contributes to the growing body
of evidence that indicates that hearts with desmo-
some mutations are more susceptible to exercise-
induced dysfunction than those without a desmosome
mutation.
Although this AAV model is efﬁcient and relatively
inexpensive compared with other methods of inves-
tigation, it falls short in a few ways. First, the path-
ological hallmarks of disease are largely absent,
including a lack of ﬁbrofatty scar, plakoglobin
redistribution, or even ultrastructural changes in the
cardiac desmosome by transmission electron micro-
scopy. Still, Cruz et al. (6) demonstrated punctate
junctional distribution of the principal gap junction
protein connexin-43 (Cx43) in exercised mutant
mice compared with continuous distribution of Cx43
at myocyte junctions in sedentary mutant mice.
Abnormal Cx43 distribution is an important, yet
nonspeciﬁc, histological feature of ARVD/C (14).
Although the authors reported a small increase in the
QRS duration in mutant mice compared with con-
trols, they did not show signiﬁcant arrhythmias or
decreased survival as a consequence of mutant PKP2
overexpression.
Aerobic exercise has remarkable cardiovascular
beneﬁts, decreasing the risk of atherosclerosis,
reducing death from heart failure, lowering blood
pressure, decreasing abdominal fat, lowering glyco-
sylated hemoglobin in diabetes mellitus, and
improving sarcopenia (15–18); however, endurance
athletics is not without some risk. La Gerche et al. (19)
investigated 40 subjects who participated in endur-
ance races (3 to 11 h in duration) and showed thatthis level of exercise causes acute RV, but not left
ventricular, dysfunction. The mechanism of RV
dysfunction in response to exercise is not known. One
simple explanation is that the thin-walled RV is
stretched by the larger volumes and cardiac output
required by aerobic activity, and desmosome muta-
tions cause a loss of myocyte cell adhesion, which
worsens the response to exercise. Although this
explanation is appealing, it does not adequately
account for some of the other mechanistic data
published for ARVD/C. Several investigations
have highlighted an important role for diminished
Wnt/b-catenin signaling in ARVD/C, although exer-
cise appears to stimulate the canonical Wnt pathway
(20,21). Peroxisome proliferator–activated receptor
(PPAR)-g and PPAR-a stimulation of induced pluri-
potent stem cell–derived cardiomyocytes from pa-
tients with ARVD/C leads to exaggerated lipogenesis
and apoptosis,which implicates this pathway inARVD/
C pathogenesis (22). Because exercise upregulates the
PPAR-g pathway, this may contribute to the harmful
effects of exercise for patients with ARVD/C (23).
As several groups continue to address these
tantalizing questions regarding the pathogenic effects
of exercise, improved understanding of the interac-
tion of desmosome mutations, aerobic activity, and
cardiac metabolism should lead to better estimation
of risk andmore effective therapies to prevent ARVD/C
and sudden cardiac death.
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